A gene from a firefly has been added to mammalian cells so that they glow when exposed to the toxin, dioxin, and the cells glow brighter as the level of dioxin increases, making them a quick and simple test for the chemical in foods, animal feeds, and tissue.
One hundred forty-two surgeons are now approved to perform the sentinel node biopsy procedure as part of two breast cancer clinical trials sponsored by the National Cancer Institute (NCI). These surgeons are in 35 states throughout the United States, in addition to Washington, D.C., and three Canadian provinces. Both studies, however, continue to actively seek additional surgeons to participate. NCI, in Bethesda, Md., is sponsoring these trials because the long-term effects of sentinel node biopsy in breast cancer remain unproven.
An NIH Consensus Panel has recommended a comprehensive approach to life long care for PKU. People with the rare metabolic disorder phenylketonuria need to adhere to the special diet central to their treatment, concluded a Consensus Panel convened by the National Institutes of Health. The conclusion addresses a long-standing difference of opinion about whether people with phenylketonuria could abandon the diet after early childhood. Get the full consensus statement in today's Vidyya.
According to a report in the current issue of The New England Journal of Medicine, an enzyme that courses through the blood in tandem with LDL (low-density lipoprotein), the carrier molecule containing "bad cholesterol," appears to play its own direct role in heart attacks.
And finally, in a story Vidyya will be monitoring closely, Ugandan officials closed schools and banned funerals as another 10 Ebola cases were diagnosed Tuesday, and the death toll from the highly infectious disease moved to at least 39.
As always, we hope you enjoy the issue.